HCPCS Level II code C9356 represents a porous, cross-linked collagen and glycosaminoglycan tendon protector sheet (Tenoglide) billed per square centimeter. The code identifies an implantable biologic device used in tendon repair and reconstruction surgeries to reduce adhesion formation and support tendon gliding. Nationally, coding for biologic tendon scaffolds is significant because it affects hospital and ambulatory surgical center supply reporting, device utilization tracking, and payment for adjunctive surgical materials.

Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and what to expect in billing practice for this device. The publication outlines benchmark pricing considerations, common payer coverage patterns, and relevant coding relationships that influence reimbursement workflows.

This summary provides clinical and administrative context to aid billing managers, clinicians, and revenue leaders in understanding where C9356 fits in surgical supply coding. Data not available in the input is noted where applicable; the piece focuses on national implications rather than state-level policy differences.